Publication date: November 2026 Source: Journal Français d'Ophtalmologie, Volume 49, Issue 9 Author(s): D. El Ghazi, M. Srour, H. Oubraham, J.F. Korobelnik, L. Kodjikian, O. Semoun, S.Y. Cohen, S. Razavi, C. Danese, F. Amoroso, C.J. Mehanna, A. Miere, E. Souied
Recommandations pratiques de la Fédération France Macula sur l’utilisation des biosimilaires des anti-VEGF. // Journal Français d'Ophtalmologie. – URL: https://www.sciencedirect.com/science/article/pii/S018155122600207X?dgcid=rss_sd_all
Recommandations pratiques de la Fédération France Macula sur l’utilisation des biosimilaires des anti-VEGF. Journal Français d'Ophtalmologie. https://www.sciencedirect.com/science/article/pii/S018155122600207X?dgcid=rss_sd_all
“Recommandations pratiques de la Fédération France Macula sur l’utilisation des biosimilaires des anti-VEGF.” Journal Français d'Ophtalmologie.
@article{article51861,
title = {Recommandations pratiques de la Fédération France Macula sur l’utilisation des biosimilaires des anti-VEGF},
journal = {Journal Français d'Ophtalmologie},
url = {https://www.sciencedirect.com/science/article/pii/S018155122600207X?dgcid=rss_sd_all}
}
Abstract Purpose To compare the efficacy of intravitreal dexamethasone (DEX) implant‐based regimen versus ranibizumab‐based regimen for managing retinal exudation and complications in stage 3 Coats' disease. Methods Thirty‐seven eyes...
Abstract Foundation models are rapidly emerging as a major development in ophthalmic artificial intelligence, largely because they can achieve strong downstream performance with fewer labelled images than conventional supervised models,...
Abstract Purpose To evaluate intraretinal fluid (IRF) volume dynamics after switching from aflibercept 2 mg to faricimab in eyes with diabetic macular oedema (DME), stratified by prior response to aflibercept. Methods This retrospective...